Literature DB >> 20103414

Unsuspected pulmonary embolism identified using multidetector computed tomography in hospital outpatients.

C Farrell1, M Jones, F Girvin, G Ritchie, J T Murchison.   

Abstract

AIM: To evaluate the incidence of unsuspected pulmonary embolism (PE) in an unselected population of outpatients undergoing contrast-enhanced multidetector computed tomography (MDCT) for indications other than the investigation of PE.
MATERIALS AND METHODS: Outpatients undergoing CT of the chest over a 6-month period were retrospectively identified and images reviewed. Inpatients and patients undergoing unenhanced CT of the chest were excluded. Data, including referring specialty, patient age and sex, reasons for examination, level of embolism, image quality, and section thickness were recorded. Radiology reports were reviewed with respect to whether or not the embolism was noted at the time of initial reporting.
RESULTS: Following exclusions 440 patients were reviewed (195 women and 245 men). PE was identified in 10 of the 440 patients, an incidence of 2.23%. One pulmonary embolus was in the main pulmonary artery, three were in lobar arteries, three in segmental arteries, and three in subsegmental arteries. Patients over the age of 60 years were more likely to have an embolism (9/300, 2.9%) compared with those under 60 years (1/140, 0.7%). Seven of the 10 positive examinations were carried out in patients who were known or later shown to have malignancy. Seven of the 10 emboli were reported at the time of initial reporting.
CONCLUSION: The outpatient population has a significant incidence of unsuspected PE. PE should be actively sought when reporting examinations performed for alternative indications, particularly where cancer is a known or suspected diagnosis. Copyright 2009 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20103414     DOI: 10.1016/j.crad.2009.09.003

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  8 in total

1.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Subsegmental pulmonary embolism: is the emperor still naked?

Authors:  Maurizio Zompatori; Domenico Attinà; Fabio Niro; Gualtiero Palareti
Journal:  Radiol Med       Date:  2013-07-15       Impact factor: 3.469

3.  Improving appropriate use of pulmonary computed tomography angiography by increasing the serum D-dimer threshold and assessing clinical probability.

Authors:  Sydney Char; Hyo-Chun Yoon
Journal:  Perm J       Date:  2014

4.  Unsuspected pulmonary thromboemboli: a continuing clinical challenge.

Authors:  Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2013

5.  Contrast enhanced chest-MDCT in oncologic patients. Prospective evaluation of the prevalence of incidental pulmonary embolism and added value of thin reconstructions.

Authors:  Silvia Tresoldi; Nicola Flor; Andrea Luciani; Maria Antonietta Lombardi; Bernardo Colombo; Gianpaolo Cornalba
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

Review 6.  Incidental venous thromboembolism: is anticoagulation indicated?

Authors:  Marcello Di Nisio; Marc Carrier
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 7.  [Diagnostics of acute pulmonary embolism : An update].

Authors:  M Das; J E Wildberger
Journal:  Radiologe       Date:  2016-06       Impact factor: 0.635

8.  Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center.

Authors:  Atul B Shinagare; Mengye Guo; Hiroto Hatabu; Katherine M Krajewski; Katherine Andriole; Annick D Van den Abbeele; Pamela J DiPiro; Mizuki Nishino
Journal:  Cancer       Date:  2011-02-11       Impact factor: 6.860

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.